CALL US TODAY FOR A FREE CONSULTATION: 800.545.3737 - 617.742.1900|ATTORNEY@SWARTZLAW.COM
Home/Dangerous Drugs

Dangerous Drugs

The Vitamin Shoppe recalls Vthrive bioactive multivitamins due to failure to meet child resistant packaging requirement; risk of poisoning

  This recall involves The Vitamin Shoppe’s Vthrive Bioactive Women’s One-Daily Multivitamins. The 60-count capsules were sold in an amber bottle with a gray top. Vthrive and Bioactive Women’s One-Daily Multi are printed on a blue label on the bottle. Item number VS-6104

The Vitamin Shoppe recalls Vthrive bioactive multivitamins due to failure to meet child resistant packaging requirement; risk of poisoning2021-04-15T12:35:40-04:00

AG Settles With Andover Pharmacy Over Illegal Opioid Prescribing

Massachusetts Attorney General Maura Healey has reached an $11 million settlement with an Andover mail-order pharmacy over allegations the company had a role in shipping thousands of illegitimate opioid painkiller prescriptions around the country.   The allegations involve Injured Workers Pharmacy (IWP) in

AG Settles With Andover Pharmacy Over Illegal Opioid Prescribing2021-04-16T12:51:53-04:00

West Virginia sues Walgreens, Rite Aid, claims they flooded state with opioids

West Virginia Attorney General Patrick Morrisey filed two lawsuits against Walgreens and Rite Aid this week, claiming they failed to monitor and report suspicious orders of controlled substances and ordered excessive amounts of opioids to their pharmacies in the state.   In the

West Virginia sues Walgreens, Rite Aid, claims they flooded state with opioids2021-04-15T17:07:38-04:00

First Big Metformin Product Recalled, More on the Way

Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway. Both Apotex Corp and Amneal Pharmaceuticals have issued a voluntary recall of its metformin hydrochloride extended-release

First Big Metformin Product Recalled, More on the Way2021-04-16T06:53:50-04:00

MEDICAL DEVICE ALERA UPGRADED TO A CLASS I RECALL BY FDA

The FDA (Food and Drug Administration) has recently upgraded the recall of Alere INRatio and INRatio2 Monitor systems to a Class I recall. This means that there is a probability that using the Alere system will cause serious health consequences or possibly lead to death.

MEDICAL DEVICE ALERA UPGRADED TO A CLASS I RECALL BY FDA2021-04-15T14:05:15-04:00

Compounding Pharmacy Update

According to the Boston Globe, on at least two occasions in the past decade, Massachusetts pharmacy officials have displayed indifference in their supervision of a concerning Framingham compounding pharmacy (The New England Compounding Center) that is linked to the nationwide meningitis outbreak that has killed

Compounding Pharmacy Update2021-04-16T05:57:24-04:00

Meningitis Sister Company Issues Massive Product Recall

The sister company of Framingham’s New England Compounding Center (NECC) – Ameridose – recalled all of its products on October 31, 2012. According to health officials, the NECC is the source of fungus-contaminated steroid injections that have killed 28 people and sickened at least 363

Meningitis Sister Company Issues Massive Product Recall2021-04-16T13:28:19-04:00

Massachusetts Pharmacy Dodged Reprimand Years Before the Outbreak

In 2004, Massachusetts health regulators proposed a formal reprimand for the pharmacy that is currently linked to the deadly nationwide meningitis outbreak – the New England Compounding Center (NECC) in Framingham, Massachusetts.   Health officials never delivered the reprimand, however, after the company protested the

Massachusetts Pharmacy Dodged Reprimand Years Before the Outbreak2021-04-15T17:22:13-04:00

More Drugs May Be Linked to U.S. Meningitis Outbreak

On Monday, October 15, U.S. health regulators announced that two other drugs produced by the New England Compounding Center (NECC), of Framingham, Massachusetts, may be linked to the meningitis outbreak.   According to the Food and Drug Administration (FDA), there is an ongoing investigation of

More Drugs May Be Linked to U.S. Meningitis Outbreak2021-04-16T13:38:39-04:00

Firm probed in Meningitis Outbreak

On October 10, an agreement with the Department of Public Health’s Board of Registration in Pharmacy was signed, stating that Ameridose and its distribution partner, Alanaus Pharmaceuticals, are voluntarily shutting down operations until October 22 to allow inspectors the access needed to conduct an investigation.

Firm probed in Meningitis Outbreak2021-04-16T13:04:11-04:00

Regulator Has Link to Firm Implicated in Meningitis Outbreak

New England Compounding Center (NECC) shares the same owners as Ameridose, a company licensed and regulated by federal authorities to manufacture medications on a large scale. Until June 2011, Ameridose’s headquarters were right around the corner from NECC in Framingham, Massachusetts. Government investigators have to

Regulator Has Link to Firm Implicated in Meningitis Outbreak2021-04-16T08:04:57-04:00

Patients in 23 States Given Steroid from Mass. Firm that is Tied to Meningitis Outbreak

U.S. health officials announced on Monday, October 8, that 13,000 patients in 23 states, including Connecticut, New Hampshire, and Rhode Island, have been exposed to a potentially hazardous steroid treatment manufactured by a Framingham compounding company.   The medication has been linked to a national

Patients in 23 States Given Steroid from Mass. Firm that is Tied to Meningitis Outbreak2021-04-16T07:24:32-04:00
Go to Top